×

Stocks GlaxoSmithKline PLC

  • The Dow and S&P snapped their winning streaks Wednesday as disappointing earnings from two of Wall Street's biggest names overshadowed another round of earnings beats.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Futures indicated a lower open for Wall Street Wednesday as cautious words from Federal Reserve Chairman Ben Bernanke and Yahoo's missing revenue expectations lent to investors taking profits.

  • Futures are higher this morning on a combination of optimism over a CIT deal, better earnings, and a bullish call from Goldman Sachs.

  • flu_outbreak3.jpg

    As flu season goes into high gear in the southern hemisphere, the U.S. Dept. of Homeland Security is preparing for a potential flu outbreak in the United States, according to its top official.

  • Perhaps reflecting concerns about the size and growth of the market for HPV shots and GSK's late entry, investors are not enthusiastic about the prestigious publication of the company's robust new test results. As I write this, GSK shares are the biggest percentage loser in big pharma.

  • Zyban Prescribing Information

    Today the Food and Drug Administration announced that Pfizer's Chantix and GlaxoSmithKline's Zyban will carry new warnings about mental side effects. Not just any old warnings, but so-called "Black Box" warnings. Or, at least, that's what we in the news media used to call them. Until the FDA called us out today.

  • Sanofi Aventis

    Shares of Sanofi-Aventis are getting a little investor injection on the back of the emergency release of the Lantus diabetic insulin studies late last Friday.

  • Sanofi Aventis

    Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus.

  • graphic_word_ofthe_street.jpg

    The bears seized control of trading on Tuesday sending the Dow sharply lower as mixed economic data and disappointing sales from Best Buy sparked worries about a recovery.

  • graphic_fast_money.jpg

    As healthcare lands squarely in Washington’s sights, how should you play the sector?

  • Stocks advanced Thursday, but ended well off their earlier highs, amid weakness in techs and consumer discretionary as oil topped $73 a barrel.

  • Pharma Stocks

    To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.

  • Stocks remained higher Thursday but pulled back somewhat after strong demand for the latest 30-year Treasury auction.

  • Stocks opened slightly higher Thursday after reports showed jobless claims fell last week and retail sales ticked higher in May.

  • Futures wavered Thursday as a quick pop after the surprise drop in jobless claims fizzled out.

  • graphic_fast_money.jpg

    It’s bathing suit time. Considering almost no one likes how they look nearly naked, what’s the trade?

  • graphic_fast_money.jpg

    For people struggling with diabetes, the bathroom scale can be the enemy. But new developments may change that and more!

  • Cramer makes the call on viewers' favorite stocks.